David Ralson | Cannabis Trades Association

David Ralson is a pioneering force in the CBD and medical cannabis sector, with nearly a decade of experience driving innovation and regulatory progress. As a key leader at British Cannabis, the UK’s largest independent cannabis company, David has been instrumental in transforming the industry through his focus on compliance, product development, and advocacy.

Since the company's founding in 2015, David has worked tirelessly to establish British Cannabis as a benchmark for quality and trust. His efforts have included collaborating with regulators to create frameworks that ensure safe, legally compliant products, and advocating for policies that benefit consumers and businesses alike.

David's leadership extends to PhytoVista, a premier testing laboratory that sets the gold standard in CBD and medical cannabis safety and compliance. Through rigorous testing protocols and a commitment to transparency, PhytoVista supports both British Cannabis and other leading brands in delivering reliable products to the market.

Under his guidance, British Cannabis has launched ground-breaking products, including the UK's first golden refined CBD elixir and clinically proven CBD cosmetics. David has also championed innovation in medical cannabis, spearheading initiatives such as Canndr.com, a platform connecting patients, doctors, and clinics, and expanding into international markets like Chile.

Committed to sustainability and social impact, David has led British Cannabis to achieve carbon-neutral status and has provided free CBD treatments to children with epilepsy for over five years.

Beyond CBD, David is driving the company’s evolution into plant-based wellness, offering natural alternatives to pharmaceuticals and expanding manufacturing services. His vision prioritises quality, compliance, and patient welfare, ensuring British Cannabis remains a trusted leader in the rapidly evolving health and wellness industry.